Lubazodone

Lubazodone
Clinical data
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	In general: uncontrolled;
Identifiers
	IUPAC name (2S)-2-[(7-fluoro-2,3-dihydro-1H-inden-4-yl)oxymethyl]morpholine;
CAS Number	161178-07-0 ;
PubChem CID	157919;
ChemSpider	138947 ;
UNII	850TB2B172;
Chemical and physical data
Formula	C14H18FNO2
Molar mass	251.296 g/mol
3D model (Jmol)	Interactive image;
	SMILES C1CC2=C(C=CC(=C2C1)F)OC[C@@H]3CNCCO3 ;
	InChI InChI=1S/C14H18FNO2/c15-13-4-5-14(12-3-1-2-11(12)13)18-9-10-8-16-6-7-17-10/h4-5,10,16H,1-3,6-9H2/t10-/m0/s1 ; Key:HTODIQZHVCHVGM-JTQLQIEISA-N ;
(what is this?) (verify)

Lubazodone (YM-992, YM-35,995) is an experimental antidepressant which was being developed as a treatment for depression and obsessive compulsive disorder, and reached phase II clinical trials, but was discontinued. It acts as a serotonin reuptake inhibitor and 5-HT_2A receptor antagonist.

References[edit]

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Clinical data

Routes of administration	Oral
ATC code	none
Legal status
Legal status	In general: uncontrolled
Identifiers
IUPAC name (2S)-2-[(7-fluoro-2,3-dihydro-1H-inden-4-yl)oxymethyl]morpholine
CAS Number	161178-07-0^Y
PubChem CID	157919
ChemSpider	138947^N
UNII	850TB2B172
Chemical and physical data
Formula	C₁₄H₁₈FNO₂
Molar mass	251.296 g/mol
3D model (Jmol)	Interactive image
SMILES C1CC2=C(C=CC(=C2C1)F)OC[C@@H]3CNCCO3
InChI InChI=1S/C14H18FNO2/c15-13-4-5-14(12-3-1-2-11(12)13)18-9-10-8-16-6-7-17-10/h4-5,10,16H,1-3,6-9H2/t10-/m0/s1^N Key:HTODIQZHVCHVGM-JTQLQIEISA-N^N
^NY (what is this?) (verify)